Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Shares Acquired by Jane Street Group LLC

Jane Street Group LLC lifted its stake in shares of Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) by 54.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 64,966 shares of the company’s stock after buying an additional 22,844 shares during the period. Jane Street Group LLC owned approximately 3.99% of Roundhill GLP-1 & Weight Loss ETF worth $1,583,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Embree Financial Group raised its holdings in shares of Roundhill GLP-1 & Weight Loss ETF by 22.6% during the fourth quarter. Embree Financial Group now owns 10,874 shares of the company’s stock worth $265,000 after purchasing an additional 2,005 shares during the last quarter. Commonwealth Equity Services LLC raised its holdings in shares of Roundhill GLP-1 & Weight Loss ETF by 80.4% during the fourth quarter. Commonwealth Equity Services LLC now owns 36,842 shares of the company’s stock worth $897,000 after purchasing an additional 16,416 shares during the last quarter. National Bank of Canada FI purchased a new position in shares of Roundhill GLP-1 & Weight Loss ETF during the fourth quarter worth $1,632,000. Finally, OLD Mission Capital LLC purchased a new position in shares of Roundhill GLP-1 & Weight Loss ETF during the fourth quarter worth $948,000.

Roundhill GLP-1 & Weight Loss ETF Stock Performance

OZEM opened at $23.85 on Monday. Roundhill GLP-1 & Weight Loss ETF has a fifty-two week low of $20.01 and a fifty-two week high of $29.21. The company has a fifty day moving average of $23.45 and a two-hundred day moving average of $24.70. The stock has a market capitalization of $34.58 million and a price-to-earnings ratio of 22.66.

Roundhill GLP-1 & Weight Loss ETF Profile

The Roundhill GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies from around the world involved in pharmaceutical drugs and supplements used for weight management. OZEM was launched on May 21, 2024 and is issued by Roundhill.